Neuropsychological Function in Relation to Serum Parathyroid Hormone and Serum 25-hydroxyvitamin D Levels. The Tromsø Study
Affiliations
There are receptors for parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D in the brain, and there are clinical and experimental data indicating that PTH and vitamin D may affect cerebral function. In the present study 21 subjects who both in the 5th Tromsø study and at a follow-up examination fulfilled criteria for secondary hyperparathyroidism (SHPT) without renal failure (serum calcium < 2.40 mmol/L, serum PTH > 6.4 pmol/L, and normal serum creatinine) and 63 control subjects were compared with tests for cognitive and emotional function. Those in the SHPT group had significantly impaired performance in 3 of 14 cognitive tests (Digit span forward, Stroop test part 1 and 2, and Word association test (FAS)) as compared with the controls, and also had a significantly higher depression score at the Beck Depression Inventory (BDI) (items 1-13). In a multiple linear regression model, a high serum PTH level was significantly associated with low performance at the Digit span forward, Stroop test part 1 and 2, and Digit Symbol tests. A low level of serum 25-hydroxyvitamin D was significantly associated with a high depression score. In conclusion, a deranged calcium metabolism appears to be associated with impaired function in several tests of neuropsychological function.
Secondary Hyperparathyroidism and Cognitive Decline.
Crepeau P, Fedorova T, Morris-Wiseman L, Mathur A Curr Transplant Rep. 2024; 10(2):60-68.
PMID: 38707996 PMC: 11068066. DOI: 10.1007/s40472-023-00394-5.
Cognitive Function and Vitamin D Status in the Chinese Hemodialysis Patients.
Zhang J, Hu J, Zhou R, Xu Y Comput Math Methods Med. 2022; 2022:2175020.
PMID: 36118837 PMC: 9481383. DOI: 10.1155/2022/2175020.
Lv Y, Wang Q, Zhang L, Zhou Q, Mi Z, Wu Y Front Surg. 2022; 9:921026.
PMID: 35965874 PMC: 9363666. DOI: 10.3389/fsurg.2022.921026.
Bahrami A, Rezaeitalab F, Farahmand S, Mazloum Khorasani Z, Arabi S, Bahrami-Taghanaki H Basic Clin Neurosci. 2021; 12(3):339-348.
PMID: 34917293 PMC: 8666927. DOI: 10.32598/bcn.2021.1910.1.
Saleh L, Almutairi F, Alorabi W, Alkuhayli B, Alzaidi S, Alzahrani S Neuropsychiatr Dis Treat. 2021; 17:711-720.
PMID: 33688194 PMC: 7936677. DOI: 10.2147/NDT.S291793.